a public good project by the
Synthesis
Company
of California

© 2026

Manuel Hidalgo | doi.page

0 works0 citations0 h-index

Manuel Hidalgo

Cleveland Clinic Florida(US)Broward Health Medical Center(US)Broward Health(US)

Publications by Year

Research Areas

Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Colorectal Cancer Treatments and Studies, Cancer Cells and Metastasis, Cancer Research and Treatments

Most-Cited Works

→ Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine(2013)6,561 cited
→ Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses(2008)4,012 cited
→ Pancreatic Cancer(2010)2,551 cited
→ Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research(2014)1,731 cited
→ Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations(2015)1,714 cited
→ Expression of Epiregulin and Amphiregulin and K-ras Mutation Status Predict Disease Control in Metastatic Colorectal Cancer Patients Treated With Cetuximab(2007)1,126 cited

→ DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer(2009)

1,069 cited

→ Gemcitabine Plusnab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial(2011)1,042 cited

→ Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies(2001)998 cited

→ Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma(2004)943 cited